相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Small molecules and targeted therapies in distant metastatic disease
P. Hersey et al.
ANNALS OF ONCOLOGY (2009)
High Levels of Circulating VEGFR2+ Bone Marrow-Derived Progenitor Cells Correlate with Metastatic Disease in Patients with Pediatric Solid Malignancies
Melissa Taylor et al.
CLINICAL CANCER RESEARCH (2009)
Dominant Effect of Antiangiogenesis in Combination Therapy Involving Cyclophosphamide and Axitinib
Jie Ma et al.
CLINICAL CANCER RESEARCH (2009)
Efficacy and Safety of Axitinib in Patients With Advanced Non-Small-Cell Lung Cancer: Results From a Phase II Study
Joan H. Schiller et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A Time-Response Model for Analysis of Drug Transport and Blood Flow Response during Iontophoresis of Acetylcholine and Sodium Nitroprusside
Erik Tesselaar et al.
JOURNAL OF VASCULAR RESEARCH (2009)
In Vivo Antitumor and Antimetastatic Activity of Sunitinib in Preclinical Neuroblastoma Mouse Model
Libo Zhang et al.
NEOPLASIA (2009)
Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: Implications for antiangiogenic drugs as chemosensitizing agents
Yuval Shaked et al.
CANCER CELL (2008)
Nonclinical Antiangiogenesis and Antitumor Activities of Axitinib (AG-013736), an Oral, Potent, and Selective Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases 1, 2, 3
Dana D. Hu-Lowe et al.
CLINICAL CANCER RESEARCH (2008)
Angiogenesis as a target in neuroblastoma
Jochen Roessler et al.
EUROPEAN JOURNAL OF CANCER (2008)
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: Results from a phase II study
Ezra E. W. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase I trial and pharmacokinetic study of bevacizumab in pediatric patients with refractory solid tumors: A children's oncology group study
Julia L. Glade Bender et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Potent antitumor effects of ZD6474 on neuroblastoma via dual targeting of tumor cells and tumor endothelium
Paul Beaudry et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Bevacizumab suppresses neuroblastoma progression in the setting of minimal disease
Thomas L. Sims et al.
SURGERY (2008)
Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study
Olivier Rixe et al.
LANCET ONCOLOGY (2007)
The addition of AG-013736 to fractionated radiation improves tumor response without functionally normalizing the tumor vasculature
Bruce M. Fenton et al.
CANCER RESEARCH (2007)
Revacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy
Paxton V. Dickson et al.
CLINICAL CANCER RESEARCH (2007)
Differential regulation of vascular endothelial growth factor by Akt and mammalian target of rapamycin inhibitors in cell lines derived from childhood solid tumors
Raushan T. Kurmasheva et al.
MOLECULAR CANCER THERAPEUTICS (2007)
AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging
Lisa J. Wilmes et al.
MAGNETIC RESONANCE IMAGING (2007)
The anti-VEGF antibody bevacizumab potently reduces the growth rate of high-risk neuroblastoma xenografts
Lova Segerstrom et al.
PEDIATRIC RESEARCH (2006)
Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: Pharmacokinetic and clinical results
HS Rugo et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Mood and lymph vessels on embryonic tumors
J Rossler et al.
HEMATOLOGICAL ONCOLOGY (2005)
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
H Hurwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Expression of VEGF receptors in cocultured neuroblastoma cells
EA Beierle et al.
JOURNAL OF SURGICAL RESEARCH (2004)
A simple way of quantifying immunostained cell nuclei on the whole histologic section
N Elie et al.
CYTOMETRY PART A (2003)
Expression of vascular endothelial growth factor and its receptor Flk-1 in human neuroblastoma using in situ hybridization
M Fukuzawa et al.
JOURNAL OF PEDIATRIC SURGERY (2002)
Potent VEGF blockade causes regression of coopted vessels in a model of neuroblastoma
ES Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
N-myc down-regulates activin A
S Breit et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
